From July 14^th to July 16^th 2023, Trade Star Pharmaceutical Holding Group marketing team successfully held the semi-annual marketing conference in Lujiang, Hefei, Anhui province, with the theme of "Forging ahead on the new journey, uniting and setting off again". The conference was attended by Li Chao, president of Trade Star Group, Sun Jie, vice president of Trade Star Group, Li Yun, executive vice president, directors and management team of each division of the marketing system and various departments of the group, representatives of each division of the marketing center and internal functional departments also participated in the conference. The conference was focused on the business development in the first half of the year and arranged the key tasks for the second half of the year.

    Sub-venue 1: Cooperative Development Division. Representatives of provincial managers from all over the country, as well as directors of the regions, had reviewed the work of the first half of 2023 one by one, and detailly reports were presented on existing problems, solution ideas, and key work plans for the second half of the year. The Cooperative Development Division is the "nerve center" of the company, and the "bridge" between the company and its customers. From the brilliant reports of each member of the Cooperative Development Division, everyone can see the confidence of the team. Sales should be backed by data. The data from the first half of the year not only tells the story of their hard work and sweat but also reflects the return for their diligent efforts.

Sub-venue of Cooperative Development Division 

Sub-venue of Cooperative Development Division 

    Sub-venue 2: Hospital Academic Promotion Division. Each regional manager has reviewed the work in the first half of the year and reported on the work and measures for the second half of the year, and clearly planned the goals for the second half of the year. The Hospital Academic Promotion Division is the major artery of the company, holding the first-hand information in clinical practice. They have absolutely control over the precise promotion of pharmaceuticals. From their work reports, we can see their dedication and meticulous work, which are admirable in terms of academic promotion.

Sub-venue of Hospital Academic Promotion Division

Sub-venue of Hospital Academic Promotion Division 

    In addition, the group arranged a training session under the theme of "professionalism, diversification, compliance, and precision". The Group's Operating Director conducted compliance training for the signing of agreements; the managers of the marketing department conducted detailed product training and knowledge assessment for the three major products of the group (Shenitong, Sheniting and Longxinsu).

Operating Director

Product Training from Marketing Department 

Product Training from Marketing Department

Knowledge Assessment of Training

    On the last day of the conference, Mr. Sun Jie, the vice president of the group summarized and explained the marketing data from the first half of 2023. Firstly, under the guidance of "focusing on terminals, concentrating on professionalism to increase sales; expanding the market, accurately reaching targets", he advocated for development and increasing volume. Secondly, under the guidance of "solving market problems and optimizing sales services", he proposed optimized solutions for the suggestions and feedback from the dealers.

Vice president of the group

    This semi-annual marketing conference specially commended the provincial and regional managers who performed excellently in the first half of the year. Their hardworking and diligent attitudes are worth beening learned from, and their pioneering spirit should be promoted in the company!

    At the end of the conference, Mr. Li Chao, the president of the group reviewed the highlights of 2023. Highlight one: Despite external influences and numerous difficulties, both revenue and profit had grown. Highlight two: The sales of Yong'an's key products have steadily increased. Highlight three: The initial success of Shenitong's market listing. Highlight four: The work on IPO standardization is progressing in an orderly manner. The year of 2023, as the first year of the group's IPO plan, aiming to become an influential listed pharmaceutical company in the industry, from product research and development to the improvement of internal control capabilities, and then to the refinement of commercial capabilities. Hoping that everyone can continue to uphold the spirit of "persistence, change, and pioneering" in the second half of the year and create more brilliance!

President of the Group

Group photo of the Conference

    After the three-day conference, in order to help everyone relax and enhance team collaboration, centripetal force, and cohesion, as well as create a healthy and positive working atmosphere, the company arranged team building activities, such as a barbecue feast, bonfire party, and more for all attendees. At the bonfire party, Mr. Li Chao, the president, and Mr. Sun Jie, the vice president, jointly ignited a torch symbolizing victory and brilliance, and a bonfire symbolizing unity and hope. The blazing fire stirs our hearts, as we marching forward with lofty aspirations.

    Just as hundreds of boats competing against the current, those who break through the waves lead the way; while a thousand sails advancing together, the brave ones take the lead. The curtain for the second half of 2023 has been unveiled, Trade Star Group will set sail with a new mission.